UBS Group’s Genfit GNFT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-5,449
| Closed | -$20.7K | – | 10762 |
|
|
2025
Q3 | $20.7K | Buy |
5,449
+1,368
| +34% | +$5.43K | ﹤0.01% | 8131 |
|
|
2025
Q2 | $15.2K | Buy |
4,081
+963
| +31% | +$3.8K | ﹤0.01% | 8623 |
|
|
2025
Q1 | $10.7K | Buy |
3,118
+70
| +2% | +$258 | ﹤0.01% | 8608 |
|
|
2024
Q4 | $11.3K | Buy |
+3,048
| New | +$14.7K | ﹤0.01% | 8244 |
|
|
2024
Q3 | – | Sell |
-346
| Closed | -$1.25K | – | 9709 |
|
|
2024
Q2 | $1.25K | Buy |
+346
| New | +$1.4K | ﹤0.01% | 8615 |
|
|
2024
Q1 | – | Sell |
-1,137
| Closed | -$4.38K | – | 9586 |
|
|
2023
Q4 | $4.38K | Buy |
+1,137
| New | +$3.77K | ﹤0.01% | 7867 |
|
|
2023
Q3 | – | Sell |
-4,330
| Closed | -$15.3K | – | 9639 |
|
|
2023
Q2 | $15.3K | Buy |
4,330
+3,370
| +351% | +$13.9K | ﹤0.01% | 6992 |
|
|
2023
Q1 | $3.94K | Sell |
960
-3,779
| -80% | -$16.2K | ﹤0.01% | 8258 |
|
|
2022
Q4 | $20.8K | Buy |
4,739
+4,394
| +1,274% | +$17K | ﹤0.01% | 7611 |
|
|
2022
Q3 | $1K | Sell |
345
-1,846
| -84% | -$7.71K | ﹤0.01% | 9958 |
|
|
2022
Q2 | $7K | Buy |
2,191
+1,088
| +99% | +$3.92K | ﹤0.01% | 8487 |
|
|
2022
Q1 | $4K | Sell |
1,103
-26
| -2% | -$106 | ﹤0.01% | 9294 |
|
|
2021
Q4 | $6K | Sell |
1,129
-2,523
| -69% | -$9.45K | ﹤0.01% | 9268 |
|
|
2021
Q3 | $14K | Buy |
3,652
+1,166
| +47% | +$4.45K | ﹤0.01% | 7580 |
|
|
2021
Q2 | $9K | Sell |
2,486
-1,014
| -29% | -$4.25K | ﹤0.01% | 8137 |
|
|
2021
Q1 | $16K | Buy |
+3,500
| New | +$18K | ﹤0.01% | 7570 |
|
|
2020
Q3 | – | Sell |
-1,273
| Closed | -$7K | – | 8153 |
|
|
2020
Q2 | $7K | Buy |
+1,273
| New | +$14.9K | ﹤0.01% | 7220 |
|
|
2019
Q4 | – | Sell |
-1,353
| Closed | -$24K | – | 8229 |
|
|
2019
Q3 | $24K | Buy |
+1,353
| New | +$23.7K | ﹤0.01% | 6629 |
|
Other funds holding GNFT
UBS Group's GNFT Position: Q4 2025 in Review
UBS Group sold out of Genfit (GNFT) in Q4 2025, closing a stake of 5,449 shares — an estimated $20.7K sold.
UBS Group first reported a position in GNFT in Q3 2019 and held it in 18 quarters. The position peaked at $24K in Q3 2019. 1 fund tracked by Wall St. Rank holds GNFT as of Q4 2025.
- UBS Group reported no remaining Genfit position as of Q4 2025 after selling out during the quarter.
- UBS Group sold 5,449 Genfit shares in Q4 2025, an estimated $20.7K.
- UBS Group first reported a position in Genfit in Q3 2019 and held it in 18 quarters.
- UBS Group's Genfit position peaked at $24K in Q3 2019.
- 1 fund tracked by Wall St. Rank held Genfit as of Q4 2025.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.